Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

22.24

+0.24 (1.09%)

At close: Mar 9, 2026, 4:00 PM EDT

22.24

0.00 (0.00%)

After-hours: Mar 9, 2026, 4:02 PM EDT

Pacira BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	726.41	700.97	674.98	666.82	541.53
Revenue Growth (YoY)	3.63%	3.85%	1.22%	23.14%	26.04%
Cost of Revenue	149.75	170.43	184.67	199.3	140.26
Gross Profit	576.66	530.54	490.31	467.53	401.28
Selling, General & Admin	368.76	294.1	269.44	254.52	199.35
Depreciation & Amortization Expenses	57.29	57.29	57.29	57.29	13.55
Research & Development	117.31	81.58	76.26	84.8	55.55
Other Operating Expenses	14.11	170.95	-0.35	10.9	42.91
Total Operating Expenses	557.47	603.91	402.63	407.5	311.35
Operating Income	19.19	-73.37	87.68	60.02	89.92
Interest Income	22.73	19.69	11.44	4.54	0.9
Interest Expense	-17.45	-16.57	-20.31	-39.98	-31.75
Other Non-Operating Income (Expense)	-7.6	7.15	-17.11	-11.29	-2.67
Total Non-Operating Income (Expense)	-2.32	10.27	-25.97	-46.72	-33.52
Pretax Income	16.87	-63.11	61.7	13.3	56.4
Provision for Income Taxes	9.84	36.45	19.75	-2.61	14.42
Net Income	7.03	-99.56	41.96	15.91	41.98
Net Income to Common	7.03	-99.56	41.96	15.91	41.98
Net Income Growth	-	-	163.72%	-62.10%	-71.15%
Shares Outstanding (Basic)	45	46	46	46	44
Shares Outstanding (Diluted)	45	46	52	47	46
Shares Change (YoY)	-2.60%	-11.03%	11.69%	1.99%	4.46%
EPS (Basic)	0.16	-2.15	0.91	0.35	0.95
EPS (Diluted)	0.16	-2.15	0.89	0.34	0.92
EPS Growth	-	-	161.77%	-63.04%	-72.37%
Free Cash Flow	0	178.75	139.49	115.2	79.85
Free Cash Flow Growth	-	28.15%	21.09%	44.27%	103.54%
Free Cash Flow Per Share	-	3.87	2.68	2.48	1.75
Gross Margin	79.39%	75.69%	72.64%	70.11%	74.10%
Operating Margin	2.64%	-10.47%	12.99%	9.00%	16.61%
Profit Margin	0.97%	-14.20%	6.22%	2.39%	7.75%
FCF Margin	0.00%	25.50%	20.67%	17.28%	14.75%
EBITDA	19.19	5.41	163.25	151.53	118.47
EBITDA Margin	2.64%	0.77%	24.19%	22.72%	21.88%
EBIT	19.19	-73.37	87.68	60.02	89.92
EBIT Margin	2.64%	-10.47%	12.99%	9.00%	16.61%
Effective Tax Rate	58.31%	-57.77%	32.00%	-19.60%	25.57%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q